Involvement of cannabinoid receptors in the intraocular pressure- lowering effects of WIN55212-2

Journal of Pharmacology and Experimental Therapeutics

Volumn 292, Issue 1, 2000, Pages 136-139

  Song, Zhao Hui ^a,b   Slowey, Carole Anne ^b  

^a University of Louisville School of Medicine   (United States)

^b TEXAS A AND M HEALTH SCIENCE CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

2,3 DIHYDRO 5 METHYL 3 (MORPHOLINOMETHYL) 6 (1 NAPHTHOYL)PYRROLO[1,2,3 DE][1,4]BENZOXAZINE; CANNABINOID RECEPTOR; CANNABINOID RECEPTOR AGONIST; RIMONABANT;

ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; DOSE RESPONSE; DOSE TIME EFFECT RELATION; DRUG EFFECT; FEMALE; INTRAOCULAR HYPERTENSION; INTRAOCULAR PRESSURE; MALE; MEASUREMENT; NONHUMAN; PRIORITY JOURNAL; RABBIT;

ADMINISTRATION, TOPICAL; ANALGESICS; ANIMALS; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG INTERACTIONS; FEMALE; INTRAOCULAR PRESSURE; MALE; MORPHOLINES; NAPHTHALENES; PIPERIDINES; PYRAZOLES; RABBITS; RECEPTORS, CANNABINOID; RECEPTORS, DRUG; STEREOISOMERISM; TIME FACTORS; TONOMETRY, OCULAR;

EID: 0033962533     PISSN: 00223565     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (26)

1. Beilin M, Aviv H, Friedman D, Vered M, Belkin M, Neumann R, Amselem S, Schwarz J and Bar-llan A (1993) HU-211, a novel synthetic non-psychotropic cannabinoid with ocular hypotensive activity. Invest Ophthalmol Vis Sci 34 (Suppl):1113.
2. Bouaboula M, Perrachon S, Milligan L, Canat X, Rinaldi-Carmona M, Portier M, Barth F, Calandra B, Pecceu F, Lupker J, Maffrand J-P, Le Fur G and Casellas P (1997) A selective inverse agonist for central cannabinoid receptor inhibits mitogen-activated protein kinase activation stimulated by insulin or insulin-like growth factor 1. J Biol Chem 272:22330-22339.
3. Colasanti BK (1986) Ocular hypotensive effect of marihuana cannabinoids: Correlate of central action or separate phenomenon? J Ocular Pharmacol 2:295-304.
4. Compton DR, Gold LH, Ward SJ, Balster RL and Martin BR (1992) Aminoalkylindole analogs: Cannabimimetic activity of a class of compounds structurally distinct from delta-9-tetrahydro-cannabinol. J Pharmacol Exp Ther 263:1118-1126.
5. D'Ambra TE, Estep KG, Bell MR, Essenstat MA, Josef KA, Ward SJ, Haycock DA, Baizman ER, Casiano FM, Beglin NC, Chippari SM, Grego JD, Kullnig RK and Daley GT (1992) Conformationally restrained analogues of pravadoline: Nanomolar potent, enantioselective, aminoalkylindole agonists of the cannabinoid receptor. J Med Chem 35:124-135.
6. Devane WA, Dysarz FA 3rd, Johnson MR, Melvin LS and Howlett AC (1988) Determination and characterization of a cannabinoid receptor in rat brain. Mol Pharmacol 34:605-613.
7. Devane WA, Hanus L, Breuer A, Pertwee RG, Stevenson LA, Griffin G, Gibson D, Mandelbaum A, Etinger A and Mechoulam R (1992) Isolation and structure of a brain constituent that binds to the cannabinoid receptor. Science (Wash DC) 258:1946-1949.
8. Flom MC, Adams AJ and Jones RT (1975) Marihuana smoking and reduced pressure in human eyes. Invest Ophthalmol 14:52-55.
9. Gaoni Y and Mechoulam R (1964) Isolation, structure and partial synthesis of an active constituent of hashish. J Am Chem Soc 86:1646-1647.
10. Green K (1984) Marijuana effects on intraocular pressure, in Glaucoma: Applied Pharmacology in Medical Treatment (Drance SM and Neufeld AH eds) pp 507-526, Grune & Stratton, New York.
11. Hepler RS and Frank IR (1971) Marihuana smoking and intraocular pressure. J Am Med Assoc 217:1392.
12. Hodges LC, Reggio PH and Green K (1997) Evidence against cannabinoid receptor involvement in intraocular pressure effects of cannabinoids in rabbits. Ophthalmol Res 29:1-5.
13. Hollister LE (1986) Health aspects of cannabis. Pharmacol Rev 38:1-20.
14. Jarho P, Urtti A, Jarvinen K, Pate DW and Jarvinen T (1996) Hydroxy-propyl-beta-cyclodextrin increases aqueous solubility and stability of anandamide. Life Sci 58:PL-181-PL-185.
15. Johnson MR and Melvin LS (1986) The discovery of nonclassical cannabinoid analgetics, in Cannabinoid as Therapeutic Agents (Mechoulam R ed) pp 121-145, CRC Press, Boca Raton, FL.
16. Matsuda LA, Lolait SJ, Brownstein MJ, Young AC and Bonner TI (1990) Structure of a cannabinoid receptor and functional expression of the cloned cDNA. Nature (Lond) 346:561-564.
17. Matsuda S, Kanemitsu N, Nakamura A, Mimura Y, Ueda N, Kurahashi Y and Yamamoto S (1997) Metabolism of anandamide, an endogenous cannabinoid receptor ligand, in porcine ocular tissues. Exp Eye Res 64:707-711.
18. Mechoulam R, Ben-Shabat S, Hanus L, Ligumsky M, Kaminski NE, Schatz AR, Gopher A, Almog S, Martin BR, Compton DR, Pertwee RG, Griffin G, Bayewitch M, Barg J and Vogel Z (1995) Identification of an endogenous 2-monoglyceride, present in canine gut, that binds to cannabinoid receptors. Biochem Pharmacol 50:83-90.
19. Mechoulam R, Feigenbaum JJ, Lander N, Segal M, Jarbe TU, Hiltunen AJ and Consroe P (1988) Enantiomeric cannabinoids: Stereospecificity of psychotropic activity. Experientia 44:762-764.
20. Melvin LS, Milne GM, Johnson MR, Subramaniam B, Wilken GH and Howlett AC (1993) Structure-activity relationships for cannabinoid receptor-binding and analgesic activity: Studies of bicyclic cannabinoid analogs. Mol Pharmacol 44:1008-1015.
21. Munro S, Thomas KL and Abu-Shaar M (1993) Molecular characterization of a peripheral receptor for cannabinoids. Nature (Lond) 365:61-65.
22. Pate DW, Jarvinen K, Urtti A, Jarho P and Jarvinen T (1995) Ophthalmic arachidonylethanolamide decreases intraocular pressure in normotensive rabbits. Curr Eye Res 14:791-797.
23. Pate DW, Jarvinen K, Urtti A, Mahadevan V and Jarvinen T (1998) Effect of the CB1 receptor antagonist, SR141716A, on cannabinoid-induced ocular hypotension in normotensive rabbits. Life Sci 63:2181-2188.
24. Porcella A, Casellas P, Gessa GL and Pani L (1998) Cannabinoid receptor CB1 mRNA is highly expressed in the rat ciliary body: Implications for the antiglaucoma properties of marihuana. Mol Brain Res 58:240-245.
25. Purnell WD and Gregg JM (1975) Delta-9-tetrahydrocannabinol, euphoria and intraocular pressure in man. Ann Ophthalmol 7:921-923.
26. Rinaldi-Carmona M, Barth F, Heaulme M, Shire D, Calandra B, Congy C, Martinez S, Maruani J, Neliat G, Caput D, Ferrara P, Soubrie P, Breliere JC and Fur GL (1994) SR141716A, a potent and selective antagonist of the brain cannabinoid receptor. FEBS Lett 350:240-244.